logo

Eledon Pharmaceuticals, Inc. (ELDN)



Trade ELDN now with
  Date
  Headline
8/1/2022 5:09:34 AM Eledon Gets FDA Clearance Of IND Application For Tegoprubart
5/31/2022 6:21:14 AM Eledon Announces Positive Topline Results From Phase 2a Trial Of Tegoprubart
5/9/2022 9:20:45 AM Eledon Pharma Doses First Patient In Phase 2a Trial Evaluating Tegoprubart In IgA Nephropathy
10/19/2021 7:20:23 AM CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement
7/2/2021 8:06:50 AM Eledon Pharma Appoints Jan Hillson To Board